Skip to main content

Branded

  • Novo Nordisk provides funding for diabetes initiatives

    NEW YORK — Diabetes organizations in several cities are getting a boost in funding from a Danish drug maker that specializes in developing treatments for the disease.

    Novo Nordisk said it would provide funding to groups in Seattle; Portland, Ore.; and Rochester, Minn., as part of the Novo Nordisk Community Care initiative. The initiative provides funding to nonprofits that support educational programs for people with Type 2 diabetes.

  • Survey: HSA participants are more engaged in managing their health

    NEW YORK — Employees who contribute to health savings accounts generally become more engaged in managing their health after enrolling, according to a survey conducted by Buck Consultants, a Xerox Company.

    For example, 51% of respondents set aside more money for potential medical costs than before they had HSAs. As many as 29% have more discussions with their doctors about the cost of care and 13% more actively manage their chronic disease.

  • Counterfeit drugs, digital technology emerge as major issues influencing health care in 2014

    NEW YORK — While the Patient Protection and Affordable Care Act will undoubtedly reshape the U.S. healthcare industry for years to come, it is only one of many factors that will emerge next year, according to a new report released Wednesday.

    The report, Top Health Industry Issues for 2014, by PwC's Health Research Institute, was based on a survey of 1,000 consumers and interviews with health industry leaders.

  • FDA seeks to limit use of antibiotics in animal feed to curb rise of resistant bacteria

    SILVER SPRING, Md. – The Food and Drug Administration is planning to limit the use of antimicrobials in food animals in an effort to stem the rise of antibiotic-resistant bacteria, the agency said Wednesday.

  • FDA advisory committee recommends approval for Takeda's vedolizumab

    DEERFIELD, Ill. — An expert panel at the Food and Drug Administration has given a thumbs-up to an experimental drug made by Takeda Pharmaceutical Co. for treating ulcerative colitis and Crohn's disease, the drug maker said.

  • Study: Despite understanding flu's seriousness, misconceptions remain

    BETHESDA, Md. — Only a quarter of respondents to a new survey would call a doctor for advice when someone at home has the flu, despite widespread recognition of it as serious and of the need for vaccination.

    The study, conducted by the National Foundation of Infectious Diseases, found that 93% of adults understand the flu is serious, while 87% understand it's highly contagious, and 66% understand the need for vaccination. The study included a national survey of 1,000 adults and surveys of 500 adults in 10 states, collected between Aug. 6 and Aug. 28.

  • Experimental AbbVie treatment regimen for hepatitis C produces 96% cure rate

    NORTH CHICAGO, Ill. — Nearly all patients taking an experimental treatment for hepatitis C developed by AbbVie were cured, the drug maker said Tuesday.

  • Walgreens: Flu disrupted vacation plans for 11 million Americans in 2012

    DEERFIELD, Ill. — More than 11 million Americans had vacation plans disrupted by the flu in 2012, according to Walgreens' recent Impact Survey, the company announced Tuesday.   

X
This ad will auto-close in 10 seconds